Brussels, 23/04/2012 (Agence Europe) - On 19 April, the European Commission cleared the planned acquisition of Synthes Inc. by Johnson & Johnson, both of them US companies active in the area of orthopaedic medical devices. The authorisation is subject to respect of pledges made by Johnson & Johnson to sell off its entire trauma business in the EEA (European Economic Area) in order to remove the overlap in this area. The detailed investigation into the deal, which started in November 2011,...